Google Übersetzer
Alx Oncology Holdings Inc.
About
Alx Oncology Holdings Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 30 2026
ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026
Apr 17 2026
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
Apr 13 2026
ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
Feb 27 2026
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb 19 2026
ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026
Recent Videos
How to Invest in ALX Oncology Holdings Inc (ALXO) Step by Step
Mar 26, 2026
ALXO STOCK : POTENTIAL BREAKOUT | ALX ONCOLOGY STOCK
Mar 02, 2026
30_01_26 Noticias de acciones biotecnológicas. Resumen diario. #Español #Shorts #diario $XBI
Jan 30, 2026
01_30_26 Biotech Stock News. Daily Recap. #English #Shorts $XBI #trading #biotechnews #dailynews
Jan 30, 2026